Specialist and experienced pricing and market access consultancy
We will develop and implement a successful launch strategy for your product.
We build payer focussed pricing and market access strategies to enable commercial success.
We provide engaging training solutions that ensures your organisation stays ahead of the ever-changing market access landscape.
Unifying our internal strengths and external partnerships helps solve your pricing and market access challenges to drive patient access of your pharmaceutical products.
Clearly and concisely communicate key scientific, economic and commercial messages to enable company employees to effectively communicate the product’s value.
Individual solutions to suit you
We adapt our working style to reflect your needs
We have a wealth of practical knowledge & experience within the pharma industry & HTA bodies
We react quickly and effectively to provide the best support possible
The Top Market Access Trends for 2026 The market access trends 2026 are being shaped by increasing g…
Read moreThe HTA Coordination Group (HTACG) has now confirmed the 2026 request periods for joint scientific c…
Read moreISPOR Europe 2025 brought together global HTA bodies, payers, industry leaders and patient organisat…
Read more2025 was a pivotal year for market access, marked by the growing convergence between scientific inno…
Read moreClinical innovation has never moved faster. Tools like single-arm designs, novel surrogates, and ada…
Read moreEvery payer ultimately asks the same question: “Compared with what?” This single question shapes…
Read moreObjectives: EUHTA regulation has applied from the 1st January 2025 for oncology pr…
Read moreObjectives: To analyse how the mandatory EU Joint Clinical Assessment (JCA) could in…
Read moreObjectives: Early-access schemes enable patients to access promising therapies—particularl…
Read more